Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.30
Ask: 3.70
Change: 0.07 (2.04%)
Spread: 0.40 (12.121%)
Open: 3.55
High: 3.75
Low: 3.50
Prev. Close: 3.43
TERN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Court Meeting & GM & Lapsing of Scheme

21 Jul 2022 13:30

RNS Number : 3388T
Pires Investments PLC
21 July 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

21 July 2022

Recommended All-Share Offer

for

Pires Investments plc ("Pires")

by

Tern plc ("Tern")

proposed to be implemented by means of a Court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006

Results of Court Meeting and General Meeting and Lapsing of Scheme

On 1 June 2022, it was announced that the Tern Directors and Pires Directors had reached agreement on the terms of a recommended all-share offer by Tern for the issued and to be issued share capital of Pires, proposed to be effected by means of a court-sanctioned scheme of arrangement (the "Scheme") between Pires and Pires Shareholders under Part 26 of the Companies Act 2006 (the "Acquisition").

Earlier today, Pires convened the Court Meeting and General Meeting in connection with the Acquisition.

At the Court Meeting, 60 out of 75 Scheme Shareholders present and voting (whether in person or by proxy) voted in favour of the Scheme, representing 53.50 per cent. in value of the Scheme Shares. While the majority of Scheme Shareholders voting and present at the Court Meeting voted in favour of the Scheme, this did not meet the requirement that Scheme Shareholders voting and present at the Court Meeting representing 75 per cent. or more in value of the Scheme Shares held by such Scheme Shareholders must vote in favour of the Scheme.

At the General Meeting, 53.75 per cent. of the Pires Shareholders present and voting (whether in person or by proxy) voted in favour of the Special Resolution, which was below the minimum threshold (75 per cent. of those shares voted) needed to approve the Special Resolution.

Accordingly, certain of the conditions to the Scheme were not satisfied and the Scheme has lapsed.

The Court Hearing to sanction the Scheme, which was expected to be held on or around 28 July 2022, will now not take place.

As a result, Pires is no longer in an offer period as defined by the City Code on Takeovers and Mergers (the "Code").

Voting results of the Court Meeting

The table below sets out the results of the poll at the Court Meeting. Each Scheme Shareholder, present in person or by proxy, was entitled to one vote per Scheme Share held at the Voting Record Time.

 

Results of Court Meeting

No. of Scheme Shares voted

% of Scheme Shares voted*

No. of Pires Shareholders who voted

% of Pires Shareholders who voted*

No. of Scheme Shares voted as % of issued share capital*

For

53,813,889

53.50%

60

80.00%

31.57%

Against

46,765,049

46.50%

15

20.00%

27.44%

Total

100,578,938

-

75

-

59.01%

* Rounded to two decimal places

Voting results of the General Meeting

The table below sets out the results of the poll at the General Meeting. Each Pires Shareholder, present in person or by proxy, was entitled to one vote per Pires Share held at the Voting Record Time.

 

For**

Against

Total

Special resolution

No. of votes

% of votes*

No. of votes

% of votes*

No. of votes

Approval of the implementation of the Scheme

68

53.75%

15

46.25%

100,822,109

Amendments to the articles

68

53.75%

15

46.25%

100,822,109

Re-registration as a private company

67

53.74%

16

46.26%

100,822,109

* Rounded to two decimal places

** Includes discretionary votes

 

The total number of Pires Shares in issue at the Voting Record Time was 170,456,642. Consequently, the total voting rights in Pires at the Voting Record Time were 170,456,642.

Capitalised terms used but not otherwise defined in this announcement have the meanings given to them in the Scheme Document published on 28 June 2022 in relation to the Acquisition.

 

 

Enquiries:

 

Pires Investments plc

Nicholas Lee, Non-Executive Director

 

+44 (0) 20 3368 8961

Cairn Financial Advisers LLP

Financial Adviser, Rule 3 Adviser and Nominated Adviser to Pires

James Lewis / Liam Murray / Ludovico Lazzaretti

 

+44 (0) 20 7213 0880

Peterhouse Capital Limited

Joint Broker to Pires

Duncan Vasey / Lucy Williams

 

+44 (0) 20 7469 0935

Tennyson Securities

Joint Broker to Pires

Peter Krens

 

+44 (0) 20 3167 7221

Yellow Jersey PR

PR advisers to Pires

Sarah Hollins / Henry Wilkinson / Annabelle Wills

 

+44 (0) 20 3004 9512

 

Notices related to the financial adviser

Cairn, which is authorised and regulated by the FCA in the UK, is acting as financial adviser and Rule 3 adviser exclusively for Pires and no one else in connection with the Acquisition and the matters set out in this announcement and will not be responsible to any person other than Pires for providing the protections afforded to clients of Cairn, nor for providing advice in relation to the Acquisition, the content of this announcement or any matter referred to herein. Cairn's responsibilities as Pires' Nominated Adviser under the AIM Rules for Companies and AIM Rules for Nominated Advisers are owed solely to London Stock Exchange and no other person. Cairn has not authorised and is not making any representation or warranty, express or implied, as to the contents of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDGDRSBDDGDB
Date   Source Headline
23rd Apr 20199:00 amEQSTern PLC: Device Authority announces new strategic partnership and joint customer collaboration for the Internet of Medical Things ('IoMT')
15th Apr 20191:00 pmEQSTern PLC: Device Authority announces new strategic alliance
11th Apr 20197:00 amEQSTern PLC: Device Authority Update - issue of further convertible loan
4th Apr 20197:01 amEQSTern PLC: Shareholder Conference Call
3rd Apr 20199:05 amRNSSecond Price Monitoring Extn
3rd Apr 20199:00 amRNSPrice Monitoring Extension
3rd Apr 20197:01 amEQSTern PLC: Equity Fundraise of c. £1.5m
1st Apr 20197:00 amEQSTern PLC: New commercial order for InVMA
26th Mar 201910:10 amEQSTern PLC: New commercial order for FundamentalVR
19th Mar 20199:10 amEQSTern PLC: Device Authority Board Appointments
19th Mar 20197:01 amEQSTern PLC: Final results for the year ended 31 December 2018
4th Mar 20197:00 amEQSTern PLC: flexiOPS Business Update
20th Feb 20197:00 amEQSTern PLC: Update re. Convertible Loan to Device Authority Limited
31st Jan 20199:30 amEQSTern PLC: Further re. Long Term Contract Win for Device Authority
14th Jan 20197:00 amEQSTern PLC: Issue of further convertible loan to Device Authority Limited
3rd Jan 20195:16 pmEQSTern PLC: Holdings in Company
31st Dec 20187:01 amEQSTern PLC: Extension of Device Authority Convertible Note Maturity Date
27th Dec 20187:01 amEQSTern PLC: Long term contract win for Device Authority and Further re Portfolio Update
11th Dec 201812:30 pmEQSTern PLC: Device Authority Contract Win
27th Nov 201811:05 amRNSSecond Price Monitoring Extn
27th Nov 201811:00 amRNSPrice Monitoring Extension
23rd Nov 20182:34 pmEQSTern PLC: Holdings in Company
22nd Nov 20187:00 amEQSTern PLC: Portfolio Update
13th Nov 20184:29 pmEQSTern PLC: AIM Director Disclosure Update
30th Oct 20187:01 amEQSTern PLC: Additional Investment in FundamentalVR
17th Sep 20187:01 amEQSTern PLC: Unaudited Interim Results for the six months to 30 June 2018
14th Sep 20187:01 amEQSTern PLC: Issue of further loan to Device Authority Limited
31st Aug 20185:00 pmEQSTern PLC: Total Voting Rights
22nd Aug 20187:00 amEQSTern PLC: Notice of Results and Shareholder Conference Call
15th Aug 20187:00 amEQSTern PLC: Fundamental Surgery Launched in the US
13th Aug 20187:01 amEQSTern PLC: Change of adviser
13th Aug 20187:01 amEQSTern PLC: Change of Adviser
10th Aug 20182:00 pmRNSPrice Monitoring Extension
8th Aug 20183:10 pmEQSTern PLC: Updated Director Information
8th Aug 20187:00 amEQSTern PLC: Director/PDMR Dealing
7th Aug 20184:40 pmRNSSecond Price Monitoring Extn
7th Aug 20184:35 pmRNSPrice Monitoring Extension
7th Aug 20188:00 amEQSTern PLC: DA Recognised as 2018 Emerging Star in IoT Security Market
3rd Aug 20184:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20184:35 pmRNSPrice Monitoring Extension
3rd Aug 20187:00 amEQSTern PLC: Statement re: Device Authority Forecasts from September 2017
25th Jul 201811:05 amRNSSecond Price Monitoring Extn
25th Jul 201811:00 amRNSPrice Monitoring Extension
25th Jul 20188:40 amEQSTern PLC: InVMA Acquires Assets from AMIHO Technology
25th Jul 20187:00 amEQSTern PLC: Equity Fundraise of c. £2.9m
11th Jul 20188:00 amEQSTern PLC: Thales and Device Authority officially launch solution to secure the Connected Health industry
10th Jul 20187:00 amEQSTern PLC: Additional Investment in InVMA
3rd Jul 20184:40 pmRNSSecond Price Monitoring Extn
3rd Jul 20184:35 pmRNSPrice Monitoring Extension
25th Jun 20189:00 amEQSTern PLC: InVMA Announces Contract with ESAB

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.